Rehmann Capital Advisory Group Has $514,000 Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

Rehmann Capital Advisory Group decreased its position in DocuSign, Inc. (NASDAQ:DOCU) by 4.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 8,085 shares of the company’s stock after selling 401 shares during the period. Rehmann Capital Advisory Group’s holdings in DocuSign were worth $514,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new position in shares of DocuSign in the 3rd quarter worth approximately $28,000. Brooklyn Investment Group acquired a new position in shares of DocuSign in the 3rd quarter worth approximately $33,000. Reston Wealth Management LLC acquired a new position in shares of DocuSign in the 3rd quarter worth approximately $47,000. nVerses Capital LLC acquired a new position in shares of DocuSign in the 2nd quarter worth approximately $48,000. Finally, Quarry LP acquired a new position in shares of DocuSign in the 2nd quarter worth approximately $53,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Stock Performance

Shares of DOCU opened at $94.52 on Friday. The firm has a market capitalization of $19.19 billion, a price-to-earnings ratio of 19.53, a PEG ratio of 11.08 and a beta of 0.92. The business’s fifty day moving average price is $76.80 and its two-hundred day moving average price is $62.86. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Citigroup increased their price target on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Wells Fargo & Company increased their price target on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Friday, December 6th. Piper Sandler increased their price target on DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Finally, Robert W. Baird increased their price target on DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $92.45.

Insider Buying and Selling at DocuSign

In other news, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the transaction, the director now owns 906,430 shares of the company’s stock, valued at $87,959,967.20. This represents a 39.08 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 7,648 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $62.47, for a total value of $477,770.56. Following the completion of the transaction, the chief executive officer now directly owns 115,589 shares in the company, valued at approximately $7,220,844.83. This trade represents a 6.21 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 651,184 shares of company stock worth $60,878,829. Insiders own 1.66% of the company’s stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.